...
首页> 外文期刊>Bulletin of experimental biology and medicine >Efficiency of Recombinant Thymosin beta 4 in Spontaneous Mouse Model of Chronic Dermatitis
【24h】

Efficiency of Recombinant Thymosin beta 4 in Spontaneous Mouse Model of Chronic Dermatitis

机译:重组胸腺素β4在慢性皮炎的自发小鼠模型中的效率。

获取原文
获取原文并翻译 | 示例

摘要

The therapeutic efficiency of recombinant thymosin beta 4 (rT beta 4) synthesized by us was studied in vivo on spontaneous CBRB mouse model that is adequate to human chronic dermatitis. Three applications of the drug during a week significantly alleviated symptoms of the disease in female mice, and in complex with subsequent antibacterial and antifungal therapy led to a pronounced and lasting (2 months) therapeutic effect. The results attest to a possibility of using rT beta 4 in combination with the known treatment protocols for chronic inflammatory diseases of the skin.
机译:我们在足以适应人类慢性皮炎的自发性CBRB小鼠模型上体内研究了我们合成的重组胸腺素beta 4(rT beta 4)的治疗效率。一周内该药的三种应用可显着减轻雌性小鼠的疾病症状,并与随后的抗菌和抗真菌治疗相结合,可产生明显且持久的治疗效果(2个月)。结果证明了将rT beta 4与已知的治疗方案结合使用可治疗皮肤慢性炎性疾病的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号